# Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device

> **NCT02524860** · NA · UNKNOWN · sponsor: **Focal Healthcare Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Focal-Fusion Bx

## Key facts

- **NCT ID:** NCT02524860
- **Lead sponsor:** Focal Healthcare Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02524860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02524860, "Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02524860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*